Brief: Iterum Therapeutics On April 3, Received Letter From Nasdaq Indicating That It Is Not In Compliance With Nasdaq Listing Rule
April 5 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS: ON APRIL 3, RECEIVED LETTER FROM
NASDAQ
INDICATING THAT IT IS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE
Source text for Eikon: [ID:https://bitly.ws/3hvaY]
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity